Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Other Non-Current Liabilities (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) recorded Other Non-Current Liabilities of $1.26 billion in Q2 2026, up 5.4% from $1.2 billion a year earlier and up 0.4% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Vertex Pharmaceuticals reported Other Non-Current Liabilities of $1.27 billion, up 25.1% from FY2024.

  • Annual Other Non-Current Liabilities has increased for eight straight years, with a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $1.01 billion in FY2024 (+15.6%), $877.7 million in FY2023 (+28.0%), $685.8 million in FY2022 (+126.1%) and $303.3 million in FY2021 (+60.0%).
  • Quarterly Other Non-Current Liabilities has ranged from $127.2 million in Q3 2022 to $1.27 billion in Q4 2025 over the past five years.
  • On a year-over-year basis, Other Non-Current Liabilities has increased for 15 consecutive quarters, with growth averaging 20.7% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 583.4% in Q3 2023, against a decline of 56.0% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.26 billion (Q1 2026), $1.27 billion (Q4 2025) and $1.23 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Bn
Mar 31, 2026 1.26 Bn
Dec 31, 2025 1.27 Bn
Sep 30, 2025 1.23 Bn
Jun 30, 2025 1.20 Bn
Mar 31, 2025 951.90 Mn
Dec 31, 2024 1.01 Bn
Sep 30, 2024 933.30 Mn
Jun 30, 2024 876.80 Mn
Mar 31, 2024 853.60 Mn
Dec 31, 2023 877.70 Mn
Sep 30, 2023 869.30 Mn
Jun 30, 2023 759.30 Mn
Mar 31, 2023 726.50 Mn
Dec 31, 2022 685.80 Mn
Sep 30, 2022 370.10 Mn
Jun 30, 2022 375.00 Mn
Mar 31, 2022 475.40 Mn
Dec 31, 2021 303.30 Mn
Sep 30, 2021 485.47 Mn
API Access

Vertex Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=VRTX&period=max&api_key=YOUR_API_KEY